1-4 of 4
Sebastian Schellong, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rivaroxaban Versus Fondaparinux in the Treatment of Superficial Vein Thrombosis - the Surprise Trial

Jan Beyer-Westendorf, MD, Sebastian Schellong, MD, Horst Gerlach, MD, Katja Jersemann, Eberhard Rabe, MD, Kurtulus Sahin, Rupert Bauersachs, MD PhD
Journal: Blood
Blood (2016) 128 (22): 85.
https://doi.org/10.1182/blood.V128.22.85.85
Published: 2016
Journal Articles

Dabigatran Etexilate or Warfarin in the Treatment of Acute Venous Thromboembolism in Western European Patients: A Pooled Analysis of RE-COVER ® and RE-COVER II™

Sebastian Schellong, MD, Henry Eriksson, MD PhD, Samuel Z. Goldhaber, MD, Martin Feuring, MD, Stefan Hantel, PhD, Jörg Kreuzer, MD, Sam Schulman, MD PhD, Ajay K Kakkar, MB, BS, PhD
Journal: Blood
Blood (2015) 126 (23): 4730.
https://doi.org/10.1182/blood.V126.23.4730.4730
Published: 2015
Journal Articles

Benefit of Extended Maintenance Therapy for Venous Thromboembolism with Dabigatran Etexilate Is Maintained Over 1 Year of Post-Treatment Follow-up

Sam Schulman, MD, PhD, David Baanstra, MD, Henry Eriksson, MD, Samuel Z. Goldhaber, MD, Ajay Kakkar, MD, Clive Kearon, MD, PhD, Sebastian Schellong, MD, Jeffrey Friedman, MD
Journal: Blood
Blood (2012) 120 (21): 21.
https://doi.org/10.1182/blood.V120.21.21.21
Published: 2012
Journal Articles

Incidence and Disease Pattern of Venous Thrombembolism after Radical Prostatectomy.

Jan Beyer, MD, Sven Wessela, MD, Oliver Hakenberg, MD, Manfred Wirth, MD, Sebastian Schellong, MD
Journal: Blood
Blood (2005) 106 (11): 1627.
https://doi.org/10.1182/blood.V106.11.1627.1627
Published: 2005